We also found that the frequency of CD4+FoxP3+ Tregs expressing ILT2 was higher in patients with melanoma compared to healthy donors (n = 11 and 11, respectively; P = 0.003; Figure 3D). The gene discussed is FOXP3; the disease is melanoma.